Lnk prevents inflammatory CD8+ T-cell proliferation and contributes to intestinal homeostasis

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1622-1632

  Katayama, Hiroko ^a   Mori, Taizo ^a   Seki, Yoichi ^a   Anraku, Masaki ^a   Iseki, Masanori ^a   Ikutani, Masashi ^b   Iwasaki, Yukiko ^a   Yoshida, Nobuaki ^c   Takatsu, Kiyoshi ^b,d   Takaki, Satoshi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Toyama Prefectural Institute for Pharmaceutical Research   (Japan)

Author keywords

Autoimmune disease; Cytokine signaling; Disease associated gene; IL 15

Indexed keywords

ADAPTOR PROTEIN; CD8 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 15 RECEPTOR; LNK PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; HOMEOSTASIS; IMMUNOCOMPETENT CELL; INFLAMMATION; INTERSTINAL HOMEOSTASIS; INTESTINE VILLUS; INTESTINE VILLUS ATROPHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL INTESTINE;

AUTOIMMUNE DISEASE; CYTOKINE SIGNALING; DISEASE-ASSOCIATED GENE; IL-15;

ANIMALS; ANTIGENS, CD44; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DNA-BINDING PROTEINS; HOMEOSTASIS; INFLAMMATION; INTESTINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; POLYMORPHISM, GENETIC;

EID: 84901854283     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343883     Document Type: Article

References (35)

1. Takaki, S., Sauer, K., Iritani, B. M., Chien, S., Ebihara, Y., Tsuji, K., Takatsu, K. et al., Control of B cell production by the adaptor protein lnk. Definition of a conserved family of signal-modulating proteins. Immunity 2000. 13: 599-609.
2. Li, Y., He, X., Schembri-King, J., Jakes, S. and Hayashi, J., Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J. Immunol. 2000. 164: 5199-5206.
3. Rudd, C. E., Lnk adaptor: novel negative regulator of B cell lymphopoiesis. Sci STKE. 2001. 85: pe1.
4. Takaki, S., Morita, H., Tezuka, Y. and Takatsu, K., Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med. 2002. 195: 151-160.
5. Velazquez, L., Cheng, A. M., Fleming, H. E., Furlonger, C., Vesely, S., Bernstein, A., Paige, C. J. et al., Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J. Exp. Med. 2002. 195: 1599-1611.
6. Tong, W. and Lodish, H. F., Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J. Exp. Med. 2004. 200: 569-580.
7. Tong, W., Zhang, J. and Lodish, H. F., Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005. 105: 4604-4612.
8. Buza-Vidas, N., Antonchuk, J., Qian, H., Mansson, R., Luc, S., Zandi, S., Anderson, K. et al., Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev. 2006. 20: 2018-2023.
9. Takizawa, H., Eto, K., Yoshikawa, A., Nakauchi, H., Takatsu, K. and Takaki, S., Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals. Exp. Hematol. 2008. 36: 897-906.
10. Seita, J., Ema, H., Ooehara, J., Yamazaki, S., Tadokoro, Y., Yamasaki, A., Eto, K. et al., Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc. Natl. Acad. Sci. USA 2007. 104: 2349-2354.
11. Bersenev, A., Wu, C., Balcerek, J. and Tong, W., Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J. Clin. Invest. 2008. 118: 2832-2844.
12. Gery, S., Gueller, S., Chumakova, K., Kawamata, N., Liu, L. and Koeffler, H. P., Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders. Blood 2007. 110: 3360-3364.
13. Bersenev, A., Wu, C., Balcerek, J., Jing, J., Kundu, M., Blobel, G. A., Chikwava, K. R. and Tong, W., Lnk constrains myeloproliferative diseases in mice. J. Clin. Invest. 2010. 120: 2058-2069.
14. Oh, S. T., Simonds, E. F., Jones, C., Hale, M. B., Goltsev, Y., Gibbs, K. D., Jr., Merker, J. D. et al., Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 2010. 116: 988-992.
15. Pardanani, A., Lasho, T., Finke, C., Oh, S. T., Gotlib, J. and Tefferi, A., LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 2010. 24: 1713-1718.
16. Vainchenker, W., Delhommeau, F., Constantinescu, S. N. and Bernard, O. A., New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011. 118: 1723-1735.
17. Todd, J. A., Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R. et al., Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007. 39: 857-864.
18. Hunt, K. A., Zhernakova, A., Turner, G., Heap, G. A., Franke, L., Bruinenberg, M., Romanos, J. et al., Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 2008. 40: 395-402.
19. Smyth, D. J., Plagnol, V., Walker, N. M., Cooper, J. D., Downes, K., Yang, J. H., Howson, J. M. et al., Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 2008. 359: 2767-2777.
20. Coenen, M. J., Trynka, G., Heskamp, S., Franke, B., van Diemen, C. C., Smolonska, J., van Leeuwen, M. et al., Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet. 2009. 18: 4195-4203.
21. Meresse, B., Malamut, G. and Cerf-Bensussan, N., Celiac disease: an immunological jigsaw. Immunity 2012. 36: 907-919.
22. Jabri, B., de Serre, N. P., Cellier, C., Evans, K., Gache, C., Carvalho, C., Mougenot, J. F. et al., Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000. 118: 867-879.
23. Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K. and Miyawaki, A., A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 2002. 20: 87-90.
24. Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C. and Song, S. Y., Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004. 21: 527-538.
25. Zhang, X., Sun, S., Hwang, I., Tough, D. F. and Sprent, J., Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998. 8: 591-599.
26. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N. et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000. 191: 771-780.
27. Berard, M., Brandt, K., Bulfone-Paus, S. and Tough, D. F., IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J. Immunol. 2003. 170: 5018-5026.
28. Rochman, Y., Spolski, R. and Leonard, W. J., New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 2009. 9: 480-490.
29. Takaki, S., Tezuka, Y., Sauer, K., Kubo, C., Kwon, S. M., Armstead, E., Nakao, K. et al., Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J. Immunol. 2003. 170: 703-710.
30. Green, P. H. and Jabri, B., Coeliac disease. Lancet 2003. 362: 383-391.
31. Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H. et al., Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004. 21: 357-366.
32. Guris, D. L., Fantes, J., Tara, D., Druker, B. J. and Imamoto, A., Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet. 2001. 27: 293-298.
33. Sakai, K. and Miyazaki, J., A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun. 1997. 237: 318-324.
34. Lefrancois, L. and Lycke, N., Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. Curr. Protoc. Immunol. 2001. Chapter 3:Unit 3 19.
35. Takizawa, H., Kubo-Akashi, C., Nobuhisa, I., Kwon, S. M., Iseki, M., Taga, T., Takatsu, K. et al., Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood 2006. 107: 2968-2975.